Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies

Sung Won Kim, Keitaro Matsuo, Takahiro Fukuda, Masamichi Hara, Kosei Matsue, Shuichi Taniguchi, Tetsuya Eto, Mitsune Tanimoto, Atsushi Wake, Kazuo Hatanaka, Shinji Nakao, Yoji Ishida, Mine Harada, Atae Utsunomiya, Masahiro Imamura, Yoshinobu Kanda, Kazutaka Sunami, Fumio Kawano, Yoichi Takaue, Takanori Teshima

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

To review a current experience of unrelated bone marrow transplantation (BMT) with reduced-intensity conditioning (RIC) regimens, we conducted a nationwide survey with 77 patients (age, 25-68 years). The backbone RIC regimen was a combination of fludarabine or cladribine, busulfan or melphalan and total body irradiation at 2-4 Gy. Five patients died early, but 71 (92%) achieved initial neutrophil recovery. Thereafter, 36 patients (47%) died of therapy-related complications, 23 (30%) of whom died within day 100. Grades II-IV acute graft-versus-host disease (GVHD) occurred in 34 of the 68 evaluable patients (50%). In a multivariate analysis, a regimen containing antithymocyte globulin (ATG) was significantly associated with a decreased risk of acute GVHD (P = 0.041). Thirty-three patients are currently alive with a median follow-up of 439 days (28-2002 days), with an OS of 50% at 1 year. In conclusion, unrelated BMT with RIC regimens can be a curative treatment in a subset of patients.

Original languageEnglish
Pages (from-to)324-330
Number of pages7
JournalInternational Journal of Hematology
Volume88
Issue number3
DOIs
Publication statusPublished - Oct 2008

Fingerprint

Unrelated Donors
Hematologic Neoplasms
Bone Marrow Transplantation
Graft vs Host Disease
Cladribine
Busulfan
Melphalan
Antilymphocyte Serum
Whole-Body Irradiation
Neutrophils
Multivariate Analysis
Therapeutics

Keywords

  • Hematologic malignancy
  • Reduced-intensity conditioning
  • Unrelated transplantation

ASJC Scopus subject areas

  • Hematology

Cite this

Kim, S. W., Matsuo, K., Fukuda, T., Hara, M., Matsue, K., Taniguchi, S., ... Teshima, T. (2008). Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies. International Journal of Hematology, 88(3), 324-330. https://doi.org/10.1007/s12185-008-0163-7

Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies. / Kim, Sung Won; Matsuo, Keitaro; Fukuda, Takahiro; Hara, Masamichi; Matsue, Kosei; Taniguchi, Shuichi; Eto, Tetsuya; Tanimoto, Mitsune; Wake, Atsushi; Hatanaka, Kazuo; Nakao, Shinji; Ishida, Yoji; Harada, Mine; Utsunomiya, Atae; Imamura, Masahiro; Kanda, Yoshinobu; Sunami, Kazutaka; Kawano, Fumio; Takaue, Yoichi; Teshima, Takanori.

In: International Journal of Hematology, Vol. 88, No. 3, 10.2008, p. 324-330.

Research output: Contribution to journalArticle

Kim, SW, Matsuo, K, Fukuda, T, Hara, M, Matsue, K, Taniguchi, S, Eto, T, Tanimoto, M, Wake, A, Hatanaka, K, Nakao, S, Ishida, Y, Harada, M, Utsunomiya, A, Imamura, M, Kanda, Y, Sunami, K, Kawano, F, Takaue, Y & Teshima, T 2008, 'Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies', International Journal of Hematology, vol. 88, no. 3, pp. 324-330. https://doi.org/10.1007/s12185-008-0163-7
Kim, Sung Won ; Matsuo, Keitaro ; Fukuda, Takahiro ; Hara, Masamichi ; Matsue, Kosei ; Taniguchi, Shuichi ; Eto, Tetsuya ; Tanimoto, Mitsune ; Wake, Atsushi ; Hatanaka, Kazuo ; Nakao, Shinji ; Ishida, Yoji ; Harada, Mine ; Utsunomiya, Atae ; Imamura, Masahiro ; Kanda, Yoshinobu ; Sunami, Kazutaka ; Kawano, Fumio ; Takaue, Yoichi ; Teshima, Takanori. / Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies. In: International Journal of Hematology. 2008 ; Vol. 88, No. 3. pp. 324-330.
@article{9439210b1d304a60ba20417b3d81ae26,
title = "Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies",
abstract = "To review a current experience of unrelated bone marrow transplantation (BMT) with reduced-intensity conditioning (RIC) regimens, we conducted a nationwide survey with 77 patients (age, 25-68 years). The backbone RIC regimen was a combination of fludarabine or cladribine, busulfan or melphalan and total body irradiation at 2-4 Gy. Five patients died early, but 71 (92{\%}) achieved initial neutrophil recovery. Thereafter, 36 patients (47{\%}) died of therapy-related complications, 23 (30{\%}) of whom died within day 100. Grades II-IV acute graft-versus-host disease (GVHD) occurred in 34 of the 68 evaluable patients (50{\%}). In a multivariate analysis, a regimen containing antithymocyte globulin (ATG) was significantly associated with a decreased risk of acute GVHD (P = 0.041). Thirty-three patients are currently alive with a median follow-up of 439 days (28-2002 days), with an OS of 50{\%} at 1 year. In conclusion, unrelated BMT with RIC regimens can be a curative treatment in a subset of patients.",
keywords = "Hematologic malignancy, Reduced-intensity conditioning, Unrelated transplantation",
author = "Kim, {Sung Won} and Keitaro Matsuo and Takahiro Fukuda and Masamichi Hara and Kosei Matsue and Shuichi Taniguchi and Tetsuya Eto and Mitsune Tanimoto and Atsushi Wake and Kazuo Hatanaka and Shinji Nakao and Yoji Ishida and Mine Harada and Atae Utsunomiya and Masahiro Imamura and Yoshinobu Kanda and Kazutaka Sunami and Fumio Kawano and Yoichi Takaue and Takanori Teshima",
year = "2008",
month = "10",
doi = "10.1007/s12185-008-0163-7",
language = "English",
volume = "88",
pages = "324--330",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies

AU - Kim, Sung Won

AU - Matsuo, Keitaro

AU - Fukuda, Takahiro

AU - Hara, Masamichi

AU - Matsue, Kosei

AU - Taniguchi, Shuichi

AU - Eto, Tetsuya

AU - Tanimoto, Mitsune

AU - Wake, Atsushi

AU - Hatanaka, Kazuo

AU - Nakao, Shinji

AU - Ishida, Yoji

AU - Harada, Mine

AU - Utsunomiya, Atae

AU - Imamura, Masahiro

AU - Kanda, Yoshinobu

AU - Sunami, Kazutaka

AU - Kawano, Fumio

AU - Takaue, Yoichi

AU - Teshima, Takanori

PY - 2008/10

Y1 - 2008/10

N2 - To review a current experience of unrelated bone marrow transplantation (BMT) with reduced-intensity conditioning (RIC) regimens, we conducted a nationwide survey with 77 patients (age, 25-68 years). The backbone RIC regimen was a combination of fludarabine or cladribine, busulfan or melphalan and total body irradiation at 2-4 Gy. Five patients died early, but 71 (92%) achieved initial neutrophil recovery. Thereafter, 36 patients (47%) died of therapy-related complications, 23 (30%) of whom died within day 100. Grades II-IV acute graft-versus-host disease (GVHD) occurred in 34 of the 68 evaluable patients (50%). In a multivariate analysis, a regimen containing antithymocyte globulin (ATG) was significantly associated with a decreased risk of acute GVHD (P = 0.041). Thirty-three patients are currently alive with a median follow-up of 439 days (28-2002 days), with an OS of 50% at 1 year. In conclusion, unrelated BMT with RIC regimens can be a curative treatment in a subset of patients.

AB - To review a current experience of unrelated bone marrow transplantation (BMT) with reduced-intensity conditioning (RIC) regimens, we conducted a nationwide survey with 77 patients (age, 25-68 years). The backbone RIC regimen was a combination of fludarabine or cladribine, busulfan or melphalan and total body irradiation at 2-4 Gy. Five patients died early, but 71 (92%) achieved initial neutrophil recovery. Thereafter, 36 patients (47%) died of therapy-related complications, 23 (30%) of whom died within day 100. Grades II-IV acute graft-versus-host disease (GVHD) occurred in 34 of the 68 evaluable patients (50%). In a multivariate analysis, a regimen containing antithymocyte globulin (ATG) was significantly associated with a decreased risk of acute GVHD (P = 0.041). Thirty-three patients are currently alive with a median follow-up of 439 days (28-2002 days), with an OS of 50% at 1 year. In conclusion, unrelated BMT with RIC regimens can be a curative treatment in a subset of patients.

KW - Hematologic malignancy

KW - Reduced-intensity conditioning

KW - Unrelated transplantation

UR - http://www.scopus.com/inward/record.url?scp=60049094881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60049094881&partnerID=8YFLogxK

U2 - 10.1007/s12185-008-0163-7

DO - 10.1007/s12185-008-0163-7

M3 - Article

VL - 88

SP - 324

EP - 330

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 3

ER -